Dynamis Pharmaceuticals
Jenkintown, US · Delaware corporation
Founders & leadership
AT
Annette TobiaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$997K disclosed across 2 rounds · 2017–2018
▶$458KraisedAug 2018 · 16 investors · PharmaceuticalsRule 506(b)
▶$458KraisedAug 2018 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David SmithExecutive Officer, Director
- Annette TobiaExecutive Officer, Director
- Offering amount
- $458K
- Amount sold
- $458K
- Minimum investment
- $2K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$539KraisedJun 2018 · 15 investors · PharmaceuticalsRule 506(b)
▶$539KraisedJun 2018 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Annette TobiaExecutive Officer
- Amount sold
- $539K
- Minimum investment
- $3K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Dynamis Pharmaceuticals raised?
- Dynamis Pharmaceuticals has disclosed $997K raised across 2 rounds.
- Where is Dynamis Pharmaceuticals headquartered?
- Dynamis Pharmaceuticals is headquartered in Jenkintown, US.